Literature DB >> 17707344

A domain of the Leptospira LigB contributes to high affinity binding of fibronectin.

Yi-Pin Lin1, Yung-Fu Chang.   

Abstract

Adhesion of pathogenic Leptospira spp. to mammalian cells is mediated by their adhesins interacting with host cell receptors. In a previous study, we have identified two potential fibronectin (Fn) binding sites in central variable region (LigBCen) and C-terminal variable region (LigBCtv) of LigB, an adhesin of pathogenic Leptospira spp. In this study, we have further localized the Fn-binding site on LigBCen and found a domain of LigB (LigBCen2) (amino acids 1014-1165) strongly bound to Fn. LigBCen2 bound to a 70kDa domain of Fn including N-terminal domain (NTD) and gelatin binding domain (GBD), but with a higher binding affinity to NTD (K(d)=272nM) than to GBD (K(d)=1200nM). Except Fn, LigBCen2 also bound laminin and fibrinogen. LigBCen2 could bind MDCK cells, and blocked the binding of Leptospira on MDCK cells by 45%. These results suggest that LigBCen2 contributed to high affinity binding on NTD or GBD of Fn, laminin, and fibrinogen and mediated Leptospira binding on host cells.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17707344     DOI: 10.1016/j.bbrc.2007.07.196

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  47 in total

1.  Subunit approach to evaluation of the immune protective potential of leptospiral antigens.

Authors:  Samuel R Félix; Daiane D Hartwig; Ana Paula C Argondizzo; Éverton F Silva; Fabiana K Seixas; Amilton C P Seixas Neto; Marco A Medeiros; Walter Lilenbaum; Odir A Dellagostin
Journal:  Clin Vaccine Immunol       Date:  2011-10-26

2.  Ca-binding and spectral properties of the common region of surface-exposed Lig proteins of leptospira.

Authors:  Rajeev Raman; Yogendra Sharma; Yung-Fu Chang
Journal:  Commun Integr Biol       Date:  2011-05

3.  A zymography analysis of proteinase activity present in Leptospira.

Authors:  Madanan G Madathiparambil; Sandhanakrishnan Cattavarayane; Gayathri D Manickam; Kavita Singh; Sudhakaran R Perumana; Subhash C Sehgal
Journal:  Curr Microbiol       Date:  2010-11-06       Impact factor: 2.188

Review 4.  Leptospira as an emerging pathogen: a review of its biology, pathogenesis and host immune responses.

Authors:  Karen V Evangelista; Jenifer Coburn
Journal:  Future Microbiol       Date:  2010-09       Impact factor: 3.165

5.  Development of an enzyme-linked immunosorbent assay using a recombinant LigA fragment comprising repeat domains 4 to 7.5 as an antigen for diagnosis of equine leptospirosis.

Authors:  Weiwei Yan; Muhammad Hassan Saleem; Patrick McDonough; Sean P McDonough; Thomas J Divers; Yung-Fu Chang
Journal:  Clin Vaccine Immunol       Date:  2013-05-29

Review 6.  Leptospira: the dawn of the molecular genetics era for an emerging zoonotic pathogen.

Authors:  Albert I Ko; Cyrille Goarant; Mathieu Picardeau
Journal:  Nat Rev Microbiol       Date:  2009-10       Impact factor: 60.633

7.  Targeted mutagenesis in pathogenic Leptospira species: disruption of the LigB gene does not affect virulence in animal models of leptospirosis.

Authors:  Julio Croda; Claudio Pereira Figueira; Elsio A Wunder; Cleiton S Santos; Mitermayer G Reis; Albert I Ko; Mathieu Picardeau
Journal:  Infect Immun       Date:  2008-09-22       Impact factor: 3.441

8.  The terminal immunoglobulin-like repeats of LigA and LigB of Leptospira enhance their binding to gelatin binding domain of fibronectin and host cells.

Authors:  Yi-Pin Lin; Sean P McDonough; Yogendra Sharma; Yung-Fu Chang
Journal:  PLoS One       Date:  2010-06-24       Impact factor: 3.240

9.  Global transcriptomic response of Leptospira interrogans serovar Copenhageni upon exposure to serum.

Authors:  Kanitha Patarakul; Miranda Lo; Ben Adler
Journal:  BMC Microbiol       Date:  2010-01-29       Impact factor: 3.605

10.  The C-terminal variable domain of LigB from Leptospira mediates binding to fibronectin.

Authors:  Yi-Pin Lin; Yung-Fu Chang
Journal:  J Vet Sci       Date:  2008-06       Impact factor: 1.672

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.